Role of Medicinal Chemistry in the Discovery of Next-Generation Therapeutics

Abstract

Medicinal chemistry serves as a critical bridge between biological research and pharmaceutical development, enabling the transformation of biological insights into chemical entities with therapeutic potential. This paper reviews the pivotal role of medicinal chemistry in discovering next-generation drugs, with a focus on recent innovations such as covalent inhibitors, PROTACs (Proteolysis Targeting Chimeras), and allosteric modulators. These approaches represent a shift from conventional active-site targeting toward more selective and durable modulation of biological pathways. Additionally, the incorporation of green chemistry principles and sustainable synthesis is evaluated for their impact on drug development pipelines. The paper discusses how innovative medicinal chemistry strategies contribute to overcoming drug resistance and improving selectivity, efficacy, and safety profiles. Examples of recently approved drugs illustrate how medicinal chemistry innovations have translated into clinical success, underscoring the importance of continuous innovation in drug discovery.

KEYWORDS: Medicinal Chemistry, PROTACs, Covalent Inhibitors, Drug Resistance, Green Chemistry.